4.4 Article

TERT Promoter Mutations and Risk of Recurrence in Meningioma

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma

Adriana Olar et al.

BRAIN PATHOLOGY (2015)

Article Clinical Neurology

Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations

David E. Reuss et al.

ACTA NEUROPATHOLOGICA (2013)

Article Clinical Neurology

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system

Christian Koelsche et al.

ACTA NEUROPATHOLOGICA (2013)

Article Genetics & Heredity

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations

Priscilla K. Brastianos et al.

NATURE GENETICS (2013)

Article Multidisciplinary Sciences

TERT Promoter Mutations in Familial and Sporadic Melanoma

Susanne Horn et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO

Victoria E. Clark et al.

SCIENCE (2013)

Article Multidisciplinary Sciences

Highly Recurrent TERT Promoter Mutations in Human Melanoma

Franklin W. Huang et al.

SCIENCE (2013)

Review Oncology

Pathological classification and molecular genetics of meningiomas

Christian Mawrin et al.

JOURNAL OF NEURO-ONCOLOGY (2010)

Review Clinical Neurology

The 2007 WHO classification of tumours of the central nervous system

David N. Louis et al.

ACTA NEUROPATHOLOGICA (2007)

Review Clinical Neurology

Histological classification and molecular genetics of meningiomas

Markus J. Riemenschneider et al.

LANCET NEUROLOGY (2006)

Review Medicine, General & Internal

Medical progress: Brain tumors

LM DeAngelis

NEW ENGLAND JOURNAL OF MEDICINE (2001)